Skoči na glavni sadržaj

Stručni rad

Combination therapy with perindopril / amlodipine - optimal synergy in the treatment of arterial hypertension and cardiovascular risk reduction

Josipa Josipović ; Klinički bolnički centar Sestre milosrnice, Zagreb, Hrvatska
Dajana Katičić ; Klinički bolnički centar Sestre milosrnice, Zagreb, Hrvatska
Draško Pavlović ; Klinički bolnički centar Sestre milosrnice, Zagreb, Hrvatska


Puni tekst: hrvatski pdf 217 Kb

str. 273-278

preuzimanja: 485

citiraj

Puni tekst: engleski pdf 217 Kb

str. 273-278

preuzimanja: 863

citiraj


Sažetak

Arterial hypertension is the leading modifiable cardiovascular risk factor. In 75% of patients, the combination antihypertensive therapy is required to achieve target values of blood pressure (BP). The combination therapy leads to greater lowering of BP and faster achievement of target values whereas the fixed combination simplifies the treatment and improves the patient compliance. The combination of ACE inhibitors and calcium channel blockers, in addition to an additive effect on lowering the value of BP, provides an additional benefit in reducing the overall cardiovascular risk.

Ključne riječi

ACE inhibitors; calcium channel blockers; hypertension; perindopril; amlodipine

Hrčak ID:

146870

URI

https://hrcak.srce.hr/146870

Datum izdavanja:

21.5.2014.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.033 *